Vestal Point Capital
$3.6B Assets Reported
112 Holdings
Latest filing 2026-03-31
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| RVMD | Revolution Medicines Inc | 2,375,000 | $231M | 6.5% |
| BMRN | BioMarin Pharmaceutical Inc | 3,575,000 | $202M | 5.6% |
| ABVX | Abivax SA | 1,500,000 | $167M | 4.7% |
| NBIX | Neurocrine Biosciences Inc | 1,250,000 | $165M | 4.6% |
| ARWR | Arrowhead Pharmaceuticals Inc | 2,275,000 | $143M | 4.0% |
| ELVN | Enliven Therapeutics Inc | 3,250,000 | $127M | 3.6% |
| RGEN | Repligen Corp | 925,000 | $109M | 3.0% |
| BCAX | Bicara Therapeutics Inc | 5,425,000 | $108M | 3.0% |
| NRIX | Nurix Therapeutics Inc | 6,500,000 | $101M | 2.8% |
| APGE | Apogee Therapeutics Inc | 1,100,000 | $93M | 2.6% |
Track Vestal Point Capital's 13F portfolio: $3.6B in reported holdings, 112 positions. Top holdings, AUM, and quarterly changes on SentiSense.